Cardiff Stock Forecast & Price Target
Cardiff Stock
Price Forecast
The average stock forecast for
Cardiff Oncology Inc (CRDF) in the next 12 months is 7.14 USD. This price target corresponds to an upside
of
449.23%. The range of stock forecasts for Cardiff is 2.02 - 12.60 USD.
Based on the ratings of 14 analysts, the consensus recommendation for Cardiff is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (USD) |
2.02 |
7.14 |
7.39 |
12.60 |
| Upside |
55.38% |
449.23% |
468.85% |
869.23% |
Recommendation Trends
The latest consensus rating for Cardiff is "BUY". This is the average
recommendation of 14 analysts: 0 strong sell,
0 sell, 2 hold, 9 buy, 3 strong buy. In the previous period, 14 analysts also majorly recommmended
"BUY" for Cardiff.
Cardiff Financial Stock
Forecast
Revenue This Year
from 0.59M
Revenue Next Year
from 0.30M